Jeff, I have to disagree. I think that Nader, Scott, the Scientific Advisory Board, etc., want to see the data as soon as possible and also want to share the data with shareholders and the public at large, and also with mainstream media asap because they are confident the results are stat sig. That just expedites things - revenues, up listing, and more buying of the stock. If the trial failed, might as well move on to other indications. But I don't think that's the case.